期刊文献+

IMP3在子宫颈腺癌中的临床应用前景 被引量:1

原文传递
导出
摘要 已有多项研究表明,胰岛素样生长因子ⅡmRNA结合蛋白3(Insulin-like growth factor ⅡmRNA binding protein 3,IMP3)在多个脏器腺细胞恶性肿瘤中均高表达。子宫颈腺癌发病率较鳞癌低,但发病年龄轻,预后差,阴道镜下宫颈多点活检诊断率明显低于鳞癌,早期诊断困难。本文主要阐述IMP3在子宫颈腺癌中的临床应用前景。
出处 《中国妇幼保健》 CAS 北大核心 2012年第8期1267-1268,共2页 Maternal and Child Health Care of China
  • 相关文献

参考文献12

  • 1Zolfoheng T,Hrd T,Ma Z et al.The continuing increase in adenocarci-noma of the uterine cervix:a birth cohort phenomenon(J).Epidemiology,1996,25:252.
  • 2Ikeda K,Tate G,Suzuki T et al.IMP3/L523S,a novel immunocyto-chemical marker that distinguishes benign and malignant cells:the ex-pression profiles of IMP3/L523S in effusion cytology(J).Hum Pathol,2010.
  • 3Slosar M,Vohra P,Prasad M et al.Insulin-like growth factor mRNA binding protein 3(IMP3)is differentially expressed in benign and ma-lignant follicular patterned thyroid tumors(J).Endocr Pathol,2009,20(3):149.
  • 4Walter O,Prasad M,Lu S et al.IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype[J].2009,40(11):1528.
  • 5Noske A,Faggad A,Wirtz R et al.IMP3 expression in human ovarian cancer is associated with improved survival(J).Int J Gynecol Pathol,2009,28(3):203.
  • 6Li L,Xu H,Spaulding BO et al.Expression of RNA-binding protein IMP3(KOC)in benign urothelium and urothelial tumors(J).Hum Pathol,2008,39(8):1205.
  • 7Li D,Yan D,Tang H et al.IMP3 is a novel prognostic marker that cor-relates with colon cancer progression and pathogenesis(J).Ann Surg Oncol,2009,16(12):3499.
  • 8Christopher P,Lee CKR.妇产科诊断病理学(M).北京:北京大学医学出版社,2007:356~401.
  • 9陈杰,常晓燕.宫颈腺癌的诊断和鉴别诊断[J].中华病理学杂志,2008,37(4):272-275. 被引量:9
  • 10Liang J,Mittal KR,Wei JJ et al.Utility of p16 INK4A,CEA,Ki67,p53 and ER/PR in the differential diagnosis of benign,prema-lignant,and malignant glandular lesion of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions(J).Int J Gynecol Pathol,2007,26:71.

二级参考文献8

  • 1Young RH, Clement PB. Endocervical adenocareinoma and its variants: their morphology and differential diagnosis. Histopathology ,2002,41 ( 3 ) : 185-207.
  • 2LiangJ,Mittal KR, Wei JJ, et al. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.Int J Gynecol Pathol, 2007,26 (1) :71-75.
  • 3Giordano G, D'A dda T, Gnetti L, et al. Villoglandular adenocarcinoma of the cervix: two new cases with morphological and molecular study. Int J Gynecol Pathol,2007,26 ( 2 ) : 199-204.
  • 4Chiesa-Vottero AG, Malpica A, Deavers MT, et al. Immunohistochemical overexpression of p16 and p.53 in uterine serous carcinoma and ovarian high-grade serous carcinoma. Int J Gynecol Pathol, 2007,26(3 ) :328-333.
  • 5Nara M, Hashi A, Murata S ,et al. Lobular endecervical glandular hyperplasia as a presumed precursor of cervical adenecarcinoma independent of human papillomavims infection. Gynecol Oncol, 2007, I06(2) :289-298.
  • 6Lee KR,Rose PG. Glandular neoplasia of the cervix//Crum CP, Lee KR.. Diagnostic gynecologic and obstetric pathology. Philadephia: Elsevier Saunders,2006:366-409.
  • 7Wright TC, Kurman ILl, Ferenczy A. Precancerous lesions of the cervix, carcinoma and other tumors of the Cervix//Wilkinson EJ. Blaustein's pathology of the female genital tract. 5th ed. New York: Springer-Verlag,2001:293-298,349-361.
  • 8Ostor AG. Early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol,2000,19( 1 ) :29-38.

共引文献8

同被引文献10

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部